| Regulating Pair |
| Introduced Variation |
Mutation (-265T >C(rs5082)) of APOA2 |
Protein Info
|
| Induced Change |
Oleoylcarnitine concentration: increase (FC = 1.28) |
Metabo Info
|
| Summary |
Introduced Variation
Induced Change
|
|
|
|
|
|
|
|
| Full List of Experiment(s) Validating This Regulating Pair |
| Details of Experiment for Validating This Pair |
[1] |
| Method |
Quantifying the change of oleoylcarnitine concentration after APOA2 mutation (-265T >C(rs5082)) through ultrahigh-performance liquid chromatography-tandem mass spectroscopy based metabolomics. |
| Disease Status |
Obesity |
ICD-11: 5B81 |
| Organ/Tissue/Cell Line |
N.A. |
Plasma |
| Subcellular Location |
Secreted |
| Tested Species |
Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
|
| Details |
It is reported that mutation (-265T >C(rs5082)) of APOA2 leads to the increase of oleoylcarnitine levels compared with control group. |
|
|
|
|
|
|
|
| References |
| 1 |
Epigenomics and metabolomics reveal the mechanism of the APOA2-saturated fat intake interaction affecting obesity. Am J Clin Nutr. 2018 Jul 1;108(1):188-200.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
